key: cord-0949680-96ksjgij
authors: Tezcan, Mehmet Engin; Dogan gokce, Gizem; Sen, Nesrin; Zorlutuna kaymak, Nilufer; Ozer, Rasit Serdar
title: Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized COVID-19 patients
date: 2020-09-01
journal: New Microbes New Infect
DOI: 10.1016/j.nmni.2020.100753
sha: 91ce87e4059e492e20243db4acbb18aa9723b003
doc_id: 949680
cord_uid: 96ksjgij

Background Electrolyte abnormalities are not uncommon in Corona virus disease 2019 (COVID-19). The data of several studies suggest that various electrolyte imbalances seem to be having impact on disease prognosis. However, no study in literature primarily focused on baseline electrolyte abnormalities’ effect on disease outcome. In this study, we assessed the validity of the hypothesis: “The baseline electrolyte imbalances may be related to unfavourable outcomes in the hospitalized COVID-19 patients”. Material-Methods Design of the study was retrospective and observational. We included 408 hospitalized COVID-19 patients over 18 years old. Baseline levels of sodium, potassium, calcium and chloride were assessed. We evaluated the effect of those electrolytes’ abnormalities on intensive care unit and mechanical ventilation requirement, hospitalization duration and treatment outcome. Also, we clustered the patients based upon electrolyte levels. Thereafter, we compared the clusters according to outcome variables and then, we compared the frequency of other severe disease indices between the clusters. Lastly, we evaluated the independent factors related to COVID -19 associated deaths with multivariate analyse. Results 228 (55.8%) of the patients had at least one electrolyte imbalances at baseline. Hyponatremia was the most frequent electrolyte abnormality. Patients with hyponatremia, hypochloride or hypocalcemia respectively would have more frequent requirement of intensive care unit and mechanical ventilation; higher mortality rate and longer hospitalization. Moreover, the cluster associated with electrolyte abnormalities had unfavourable outcome. Also, clinical and laboratory features associated with severe disease were detected more often in those cluster. Furthermore, hyponatremia was found as one of the independent factors related to death from COVID-19 (OR 10.33; CI %95 1.62-65.62; p=0.01) Conclusion Baseline electrolyte imbalances, primarily hyponatremia would be related to poor prognosis in COVID-19 and baseline electrolyte assessment would be beneficial for evaluating the risk of severe COVID-19.

Chinese province of Wuhan (1). It was a potentially fatal disease with multisystem involvements. 59

However, its primary target is human respiratory system. In pulmonary system, SARS-CoV2 induces 60 severe pneumonia and cause acute respiratory stressed syndrome (2). Furthermore, the disease may 61

have an impact on various parts of the body including cardiac (3), nervous (4), renal (5), 62 gastrointestinal (6) and coagulation (7) systems. 63

Several demographic, clinical and laboratory parameters correlate with prognosis and severity 64 of COVID-19 . Hypertension and diabetes mellitus are the most prevalent co morbidities associated 65 with diseases severity (8). Likewise, lower lymphocyte and platelet counts; increased serum ferritin, 66 interleukin (IL)-6 and IL-10 levels; abnormalities in coagulation parameters such as increased d-67 dimer levels; alterations in cardiac and muscle injury parameters and abnormalities in liver and 68 kidney function biomarkers were found related to severe disease and unfavourable outcome in 69 COVID-19 (9). 70

It was shown that more than three forth of the COVID-19 patients had any kind of renal 71 involvement during the course of the disease (5). Most frequent forms of renal involvements in 72 COVID-19 are acute kidney injury, proteinuria, hematuria and electrolytes imbalances (5, 10). In a 73 metanalysis, lower concentrations of sodium, potassium and calcium, would be related to severe 74 disease (10). But, none of the included studies in this paper primarily evaluated the status of 75 electrolyte imbalances and its effect on both survival and disease severity. 76

In this study, we evaluated the validity of the hypothesis which was developed within the 77 scope of our observations: "The electrolyte imbalances at the first visit even before treatments may be 78 related to unfavourable outcomes; higher frequency of intensive care unit and mechanical ventilation 79 requirement and increased inpatient days in the hospitalized COVID-19 patients". 80

All 408 COVID-19 patients over 18 years old who hospitalized in one of the pandemic clinic 82 of tertiary healthcare facility were retrospectively taken into the study. We diagnosed COVID-19 83 through two different approaches. Firstly, all the patients with positive polymerase chain reaction 84 J o u r n a l P r e -p r o o f 4 (PCR) for SARS-CoV2 were accepted as COVID-19. Moreover, the patients with negative PCR were 85 got COVID-19 diagnosis, if they fulfilled all three clinical criteria: Having fever and/or respiratory 86 symptoms, compatible chest imaging findings (11) and decreased lymphocyte count while white blood 87 cell count is normal or decreased (12). All possible COVID-19 cases were firstly appointed to the 88 pandemic outpatient clinics of the same tertiary healthcare facility. Then, the subjects who fulfilled the 89 Turkish Health Ministry COVID-19 Guideline's criteria for hospitalization were transferred to 90 pandemic clinics. According to these criteria, the COVID-19 patients with any of four conditions were 91 hospitalized. These conditions were having any co morbidity, radiological features compatible with 92 pneumonia, age over 50 years old and having the clinical features including respiratory distress, 93 tachypnea, oxygen saturation (SPO 2 ) lower than %93 and tachycardia (13). Furthermore, patient 94 discharges were also decided according to same guideline. Herein, the COVID-19 patients who were 95 treated as inpatients, those who have not had a fever and need for oxygen within the last 48-72 hours 96 were discharged(13). 97

We collected the patients' demographic features (age, gender), co-morbidities, presenting 98 COVID-19 related symptoms, results of SARS-CoV2 PCR, treatment history for COVID-19 during 99 hospitalization, outcome, requirement of intensive care unit , requirement of mechanical ventilation, 100 duration of hospitalization, measurements of fever and SpO 2 during hospitalization, time between 101 disease onset to hospitalization, baseline disease severity (measured by National Early Warning 102 Score -NEWS-) (14) and baseline laboratory values (blood levels of electrolytes including sodium, 103 potassium, chloride, corrected calcium; other biochemical parameters including aspartate 104 aminotransferase (AST), alanine aminotransferase (ALT), creatinin, creatine kinase (CK), lactate 105 dehydrogenises (LDH), D-dimer, albumin, ferritin, C-reactive protein (CRP) and hemograms). All the 106 study parameters were obtained retrospectively from the hospital's medical records. 107

The COVID-19 treatments were administered based upon Turkish Health Ministry COVID-19 108 Guideline(13). Furthermore, requirements of intensive care unit or mechanic ventilation were decided 109 by intensive care unit specialist in reference to same guideline(13). Moreover, the patients' outcome 110 was classified as deceased or discharged The levels of the electrolytes, ALT, AST, creatinin, CK, 111 LDH, albumin, CRP were classified according to the laboratory reference ranges as normal, low or 112 J o u r n a l P r e -p r o o f 5 high. However, ferritin and D-dimer levels were classified based upon their levels related to 113 unfavourable prognosis in COVID-19. These cut off levels were specified as 300 mg/mL for ferritin 114 and 1000 mg/L for D-dimer(15). Also, we focused on white blood cell, platelet and lymphocyte 115 counts at hemogram. Platelet levels lower than 100 x10 9 per litre and lymphocyte levels lower than 116 1x10 9 per litre were accepted as cut off value for severe disease(16). In our study we corrected the 117 calcium levels based upon serum albumin levels(17). 118

In this study, our primary end points were patient's outcome, requirement of intensive care 119 unit, requirement of mechanical ventilation and duration of hospitalization. Herein, we cluster the 120 patients by baseline electrolyte levels, and then we compare these clusters according to those primary 121 end points. Moreover, we assessed the independent factors related to deaths from COVID-19. 122

Ministry prior to data collection and carried out in compliance with the Helsinki Declaration. 124

Statistical analyses were carried out using SPSS Version 17.0 (SPSS Inc., Chicago, IL, USA). 126

In order to determine if the data were normally distributed, the Kolmogorov-Smirnov test was 127 performed. None of the parameters distributed normally. Therefore, comparisons of the continuous 128 variables and categorical variables performed by Mann-Whitney u test and Chi-square test 129 respectively. For classifying the patients in accordance with electrolyte levels, we implemented two 130 step cluster analyses. Sodium, potassium, chloride, calcium levels were included to the analyses. Then, 131 we compared the clusters for primary end points. Moreover, we evaluated the independent factors 132 related to mortality from COVID-19 by multivariate analysis. Herein, we implemented binary logistic 133 regression for multivariate analyses. Furthermore, we included the variables: age, gender, disease 134 severity, time between disease onset to hospitalization, electrolyte abnormalities, co-morbidities, 135 pulmonary infiltration; fever or hypoxemia during hospitalization to the multivariate analyse. The 136 results are given as mean ± standard deviation. P-value lower than 0.05 was considered as statistically 137

J o u r n a l P r e -p r o o f 6 We included 408 hospitalized COVID-19 patients to the study. In our COVID-19 cohort, 220 140 (53.9%) of the patients were female. Mean age of the patients was 54.3±16.3 years. 267 (65.4%) of the 141 patients had SARS-CoV2 PCR positivity. The most frequent presenting symptoms of the patients were 142 cough, fever and shortness of breath. Moreover, the patients' most frequent co-morbidities were 143 diabetes mellitus, hypertension and coronary arterial diseases. Thirty-seven (9.1%) of the patients 144 transferred to ICU and 29 (7.1%) of the subjects in our cohort needed MV during their 145 hospitalization. Furthermore, 26 (6.4%) of the 408 patients were deceased (table 1) . 146

We found that 228 (55.8%) of the patients had any of the electrolyte abnormalities at baseline. 147

Hyponatremia was the most frequent baseline electrolyte abnormality. Herein, 146 (35.8%) of the 148 patients had hyponatremia. Also, 39 (9.5%) of the patients had hypocalcemia. Hypopotassemia and 149 hypochloride was found 28 (6.8%) of the patients each. Lastly, seven (1.7 %) of the participants had 150 hyperpotassemia. Furthermore, none of the patients in our cohort had hypernatremia, hyperchloremia 151 or hypercalcemia at baseline. Frequency of ICU requirement, MV requirement and mortality were 152 found higher, and duration of hospitalization were longer in patients with hyponatremia, hypochloride 153 and hypocalcemia as compared to the patients without individual electrolyte abnormalities (table 2) . 154

We classified the patient based upon electrolyte abnormalities. After administering two step 155 cluster analyses, the patients divided into two different clusters. All studied electrolytes (sodium, 156 potassium, calcium and chloride) had significant contribution for both clusters. Herein, in both 157 clusters, sodium levels were the most significant variable (figure 1A).All patients in cluster 1 had 158 normal levels of sodium, chloride, potassium and calcium. Cluster 2 patients were mainly 159 hyponatremic, normopotassemic, normocalcemic and normochloremic. However, all patients with 160 abnormal levels of potassium, sodium, calcium and chloride aggregated in cluster 2 (figure 1B). In 161 brief, cluster 1 patients were out of electrolyte abnormalities. Furthermore, even though, all patients 162 with electrolyte abnormalities were in cluster 2, main difference between two clusters was sodium 163

Patients in cluster 2 were older; had higher frequency of hypoxemia and fever during 165 hospitalization. Moreover, only fever and musculoskeletal findings as presenting symptoms were 166 different between groups. Both those presenting symptoms were more frequent in cluster 2. 167 J o u r n a l P r e -p r o o f 7 Furthermore, diabetes mellitus, hypertension and coronary arterial diseases were more often in cluster 168 2. Lastly, baseline COVID disease severity scores were higher in cluster 2 (table 3) . 169 CRP, LDH, D-dimer, creatinine, ferritin levels of the patients in cluster 2 were more 170 frequently higher than cut off values as compared to cluster 1 patients. Also, more patients in cluster 2 171 had low levels of lymphocyte counts. (table 4) . 172

In terms of outcome parameters, cluster 2 patients had worse prognosis as compared to cluster 173 1. More patients in cluster 2 deceased. Requirements of ICU and MV were more often in cluster 2. 174

Lastly, patients in cluster 2 had longer hospitalization duration with regard to cluster 1 (table 3) . 175

Lastly, we conducted multivariate analyses for evaluating the risks factors associated with 176 COVID-19 related deaths. Hyponatremia, age, disease severity, fever during hospitalization and to 177 have at least one of the co-morbidities were found as independent variables for death from COVID-19 178 (table5). 179

In the study that we evaluated the electrolyte imbalances' effect on frequency of intensive care 181 unit and mechanical ventilation requirement, hospitalization length and treatment outcome; it was 182 found that sodium, chloride and calcium abnormalities were related to unfavourable outcome. 183

Furthermore, after clustering patients based upon electrolyte imbalances, patients dived into two 184 different groups. Main difference between the groups was frequency of sodium abnormalities. Patients 185 aggregated in cluster with electrolyte imbalances had worse prognosis as compared to patients with 186 normal electrolyte levels. Furthermore, hyponatremia was found independently related to death form 187

There were several clinical and laboratory features related to severe disease in COVID-19. In 189 one study, levels of sodium, CRP, prealbumin; platelet count and pCO2 had highest predictive power 190 for severe disease(18). Also, in hospitalized patients, older age, d-dimer and high SOFA scores were 191 found relevant to mortality (15). In hemogram s, increased white blood cell counts; low lymphocyte 192 and platelet counts were more often in non-survivals (9). Furthermore, DM and hypertension were the 193 main co-morbidities related to disease severity and mortality(8). In a meta analyses, abnormalities in 194 coagulation parameters such as increased d-dimer levels; alterations in cardiac and muscle injury 195 J o u r n a l P r e -p r o o f 8 biomarkers; liver and kidney function tests were relate to severe disease and unfavourable outcome in 196 COVID-19(9). Risk factors for hospitalization and prolonged hospitalization is also studied. Herein, 197 high CRP, older age, low lymphocyte counts were found related to hospitalization(19) and 198 hypoalbuminema, increased levels of ferritin and LDH were correlated to prolonged 199 hospitalization(20). Also, several cytokines would have contribution to the pathogenesis of the 200 disease. Herein, high levels of Il-6, Il-10 and TNF were correlated with disease severity (21, 22) . 201

Likewise, serum electrolyte abnormalities may also relevant to severe disease. In a meta analysis, 202 sodium and potassium levels were significantly lower in severe COVID-19 (10). Moreover, it was 203 found that sodium, potassium and chloride levels had high predictive power for progressing to severe 204 disease(18). In our study, we showed that low baseline sodium , chloride and calcium levels related to 205 higher frequency of mortality, ICU and MV requirement and longer hospital stays. In above-referred 206 studies, various electrolyte abnormalities were found to be relevant to severe disease or poor 207 prognosis. However, hyponatremia was the common electrolyte abnormality related to unfavourable 208 outcome in these studies. Therefore, assessing baseline electrolyte levels, primarily sodium status, 209 would help physicians for risk evaluation for COVID-19 severity. 210

In a study, it was shown that sodium and Il-6 levels were inversely correlated. Also, in this 211 study, like others, sodium levels were associated with more severe outcome (23). As Il-6 is one of the 212 key cytokine for cytokine storm and poor prognosis (24), it would be speculated that low sodium 213 levels would be indirect sign of increased Il-6 levels and related to severe disease phenotype. 214

Furthermore, hyponatremia was the most prominent electrolyte abnormality that increases the 215 likehood of mortality in hospitalized patients (25). Therefore, low sodium levels would also be 216 In our study, all patients with abnormal electrolyte levels aggregated in cluster 2. Also, 223 prominent electrolyte imbalance in cluster 2 was hyponatremia. Furthermore, several demographic 224 features (older age), biochemical abnormalities (alterations in CRP, LDH, D-dimer, creatinine, ferritin 225 and lymphocyte counts) and co-morbidities (diabetes mellitus, hypertension and coronary arterial 226 diseases) relevant to severe COVID-19 (9) were also more frequent in cluster 2. Therefore, electrolyte 227 abnormalities would be detected together with some of the variables associated with poor prognosis. 228

Therefore, these electrolyte abnormalities would be a strong indicator of severe disease. 229

There were some limitations of the study. Firstly, we evaluated only limited number of 230 electrolyte's influence on disease prognosis. Furthermore, we did not assess the etiology of the 231 electrolyte abnormalities. Also, only hospitalized patients were included to the study. Therefore, the 232 data did not represent all COVID-19 patients. Lastly, as the study had retrospective and observational 233 design, we evaluated only the baseline electrolyte levels. So, the data did not show the effect of 234 subsequent electrolyte abnormalities developed during hospitalization on outcome. 235

As a result, baseline electrolyte abnormalities, mainly hyponatremia would be a sign of 236 unfavourable prognosis in COVID-19 and baseline electrolyte assessment even after hospitalization 237 would be beneficial to assessing the risk for severe COVID-19. 

The epidemiology and pathogenesis of coronavirus disease 240 (COVID-19) outbreak

Identification of a novel 242 coronavirus causing severe pneumonia in human: a descriptive study

COVID-19 and the cardiovascular system

Nervous system involvement after 247 infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity

Renal Involvement and Early Prognosis 249 in Patients with COVID-19 Pneumonia